BFB759

Bluefin Biomedicine, Inc. · Phase 2 active Biologic

At a glance

Generic name	BFB759
Sponsor	Bluefin Biomedicine, Inc.
Modality	Biologic
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa (PHASE2, PHASE3)
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BFB759 CI brief — competitive landscape report
BFB759 updates RSS · CI watch RSS
Bluefin Biomedicine, Inc. portfolio CI